Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-12-02

Clinical Trial Update: Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing umbilical cord blood-derived mesenchymal stem cells for regeneration of sweat glands and body repair in sweat gland diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Blood-Derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Sweat Gland Diseases | Phase 1 | Status: UNKNOWN